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Abstract
In Indonesia, Nasopharyngeal Carcinoma (NPC) is the most frequent cancer of the head and neck region. At first
presentation in the hospital most patients already have advanced NPC. Our previous study showed that general
practitioners (GPs) working in Yogyakarta, Indonesia lack the knowledge necessary for early detection of NPC. By providing
training on early symptoms of NPC we hope that the diagnosis and referral will occur at an earlier stage. Here we assess the
current NPC knowledge levels of GPs in Jakarta, evaluate improvement after training, compare the effectiveness of two
training formats, and estimate the loss of recall over a two week period.Methods: Two Indonesian GPs visited 31 Primary
Health Care Centres (PHCCs) and provided a lecture on NPC. The alternative format consisted of a symposium at the
Universitas Indonesia, Jakarta, presented by local head and neck surgeons, with all GPs in the region being invited. To
evaluate the effect of both formats a questionnaire was conducted before and after.
Results: The lecture in the PHCCs was attended by 130 GPs. Sixty-six GPs attended the training in the university hospital and
40 GPs attended both. Pre training the NPC knowledge level was poor with an average of 1.6 symptoms being correctly
identified out of a potential maximum of 12, this was increased to 4.9 post training (p,0.0001). GPs attending the PHCC
course recorded a greater increase in correct symptoms than those attending the symposium (3.8 vs. 2.8; p = 0.01). After a
two week period the knowledge levels had declined slightly from 5.5 correctly identified symptoms to 4.2 (p = 0.25).
Conclusion: These results confirm our findings regarding GPs insufficient knowledge of NPC. Lectures in the PHCC and a
symposium have both been proven to be effective training tools in the education of GPs.
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Introduction
The Indonesian health care sector represents a mix of public
and private providers. The government provides primary health
care centres (PHCCs). There are more than 7600 of these centres
in Indonesia. At the primary health care level, Indonesia has
relatively adequate levels of provision, for every 30 000 people one
public health centre on average. [1], [2]. The PHCCs are the first
recourse for Indonesians seeking medical attention, with referral to
a hospital occurring when deemed necessary.
Cancer is increasingly recognized as leading cause of death in
Indonesia, and nasopharyngeal carcinoma (NPC) is the most
frequent cancer in the head and neck area and is the fourth most
common tumour occurring in males. The incidence is estimated 6
per 100000, leading to at least 14000 new cases per year [3].
However this may be an underestimation due to poor cancer
registration. In most countries NPC is an orphan disease with a
worldwide incidence of 80000 new cases per year. However, in
Southern China and most of South-East Asia NPC is endemic
with a yearly incidence reaching as high as 20–50 cases per
100000 annually [4],[5].
NPC arises in the epithelial lining of the nasopharynx. This
neoplasm is frequently seen at the pharyngeal recess (Rosenmu¨l-
ler’s fossa) posteromedial to the medial crura of the eustachian
tube opening in the nasopharynx [6].
NPC patients present themselves with symptoms from the
following categories: (1) presence of tumour mass in the
nasopharynx (epistaxis, nasal obstruction, nasal discharge); (2)
dysfunction of the Eustachian tube (tinnitus, hearing loss); (3) skull
base erosion and palsy of the 5th and 6th nerve (headache,
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diplopia, facial pain and numbness); and (4) neck mass (painless
enlargement of the upper cervical lymph node). The early
symptoms such as epistaxis and tinnitus are not specific for
NPC, which makes it difficult to diagnose at an early stage [6].
The Epstein-Barr virus is known as the first tumour virus and
was associated with NPC in 1970 [7]. Other risk factors of NPC
are environmental co-carcinogens, i.e. high levels of volatile
nitrosamines and butyrate derivatives in preserved food, especially
in salty-preserved fish and dried meat, alcohol and smoking [8–
11]. Non-environmental risk factors are gender, ethnicity and
family history [12,13].
A majority of patients present with a loco-regional disease most
often with an advanced lymph node metastasis in the neck [14,15].
Accordingly the most common symptom at presentation is a
painless mass in the neck [15]. Presently, at intake in the hospital
Cipto Mangunkusumo hospital/University of Indonesia, Jakarta
88% of new patients already have advanced NPC. (Adham et al;
Chin J Cancer, submitted). The standard treatment for primary
NPC is radiotherapy to which NPC is sensitive, however in
advanced cases additional chemotherapy is needed. A recent meta
analysis proved the clinical benefit of concurrent chemo-radiation
therapy compared with radiotherapy alone in the treatment of
advanced NPC in endemic areas [16]. The most important
prognostic factor is presenting stage [6,17]. Patients with early
stage disease (T1, T2 and N0-1 without distant metastasis) can
achieve a five years overall survival of 85% compared to 66% in
patients with late stage disease (T3, T4 and N2, N3 without distant
metastasis) [17]. The 10-year disease free survival for early stage
NPC is 67–71% while for late stage disease this is 29–54%. [18].
One possible reason for the high percentage of patients with
advanced NPC could be a delay in referral due to poor diagnosis. In
our previous study we assessed the knowledge on NPC of the GPs
working in the PHCC in the Yogyakarta region [19]. Our results
indicated that the knowledge of GPs is insufficient with many not
being aware of the high incidence of NPC in their region.
In this study we (1) assess the current knowledge concerning
NPC of GPs working in the Jakarta region, (2) evaluate the
improvement provided by additional training, (3) compare the
effectiveness of two different training formats, and (4) estimate the
loss of recall over a two week period. By providing additional
training about NPC and its early symptoms we hope to increase
the diagnosis and referral of patients with early stage NPC. An
early detection program for breast cancer, cervical cancer and
NPC was proven to be effective for down staging breast cancer
and cervical cancer, however the training was not sufficient to
result in a down staging of NPC [20]. We anticipate our early
detection-training program to be more effective since we only
focus on NPC.
Methods
Study population
For this study we invited GPs from two of the five districts of the
province Jakarta.
The study population consists of three groups: (1) GPs who only
attended the lecture at their own PHCC; (2) those who only
attended the symposium at the hospital Cipto Mangunkusumo
(Universitas Indonesia, Jakarta); and (3) those who attended the
lecture at the PHCC followed by the symposium at the hospital
Cipto Mangunkusumo.
Approval for both the visit at the PHCCs as well as for the
symposium was given by the head of public health department for
the province Jakarta, and a letter of approval was presented at
each PHCC visited. For study design see figure 1.
Questionnaire
Data were collected utilizing a revised questionnaire, based on
the one described in a previous study [19], which consisted of four
sections: (1) general information questions concerning the GP,
such as the number of years experience, and the number of
patients seen per year; (2) questions concerning NPC, such as early
symptoms and risk factors; (3) questions concerning the experience
in daily practice regarding the extent to which a GP was
confronted with NPC and his/her response for suspected NPC;
and (4) questions regarding the ambition and wishes regarding
future education on NPC.
The questions regarding early symptoms and risk factors
allowed for the GP to list as many as he/she thought appropriate,
Figure 1. Study design.
doi:10.1371/journal.pone.0032756.g001
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while the questions concerning prevalence of NPC were multiple
choice questions. The questionnaire was completed both prior to
and after the NPC training session. All questionnaires were
finished within 20 minutes, and were made in anonymity.
Primary health care centres (PHCCs)
PHCCs in the Jakarta region were visited by two physicians.
The GPs working at these centres were invited to participate in the
study. GPs were not informed forehand as to the purpose of the
visit. The training session consisted of a lecture designed by a team
of Head and Neck surgeons from Rumah Sakit CiptoMangunku-
sumo/University of Indonesia, Jakarta, Indonesia and the Nether-
lands Cancer Institute/Antoni van Leeuwenhoek hospital. This
lecture focused on all aspects of NPC, especially on early
symptoms and best referral strategy. Two Indonesian physicians
who have been trained and examined by the same Head and Neck
surgeons presented the lecture. The lecture was given in the
Indonesian language. The lecture lasted for 35 minutes and
afterwards there was time for discussion.
Symposium
All GPs visited by the two physicians in the PHCCs were invited
to a subsequent symposium on NPC (one to four weeks thereafter) at
the Cipto Mangunkusumo University Hospital in Jakarta, Indone-
sia. The symposium consisted of a lecture on the risk factors,
symptoms, incidence, referral system concerning NPC patient, in
addition a physical examination training of the head and neck was
provided. The symposium was accredited by the Indonesian
Medical Association. The training and lectures lasted for four hours.
Statistical Methods
Analyzed were the questions concerning NPC symptoms, risk
factors and age at presentation. The listed NPC symptoms and risk
factors were designated as being correct or incorrect, and in the
case of the former being one of 12 possible correct symptoms. As a
result the number of correctly listed symptoms was binomial (listed
or not listed) for the 12 cases. Similarly for the questions
concerning youngest and peak age at presentation the outcome
was taken as correct or incorrect. While for the number of
incorrectly listed symptoms, the number of correctly listed risk
factors and the number of incorrectly listed risk factors, we assume
the outcome to be Poisson distributed. These outcomes were
modelled using generalized linear mixed effects models (GLMMs),
either logistic or Poisson mixed effects models. In all models doctor
ID is the random intercept with an unstructured covariance
matrix. Fixed effect covariates included teaching format (PHCC
vs. symposium), time (pre- or post-training), work experience (0–
10, 11–20, 20+ years) and the pair-wise interactions of these. The
12 correct symptoms were divided into four categories (for details
see figure 2); this covariate and its interaction with other covariates
were also included as fixed effects in the model for correct
symptoms. The only covariate missing data was the number of
work experience years, which was imputed using the median. In
these analyses only data from the doctors attending a training
session for the first time was employed.
The symposium data from the doctors who had previously
attending the PHCC trainings was used to assess the loss in recall
over the 2 week period between PHCC and symposium training
sessions. In these analyses the GLMMs included a four level factor
representing the four assessments for these individuals (PHCC pre-
training, PHCC post-training, symposium pre-training, sympo-
sium post-training) as a fixed effect. The interest being in the
change in knowledge between PHCC post-training session and the
symposium pre-training session.
In all models, fixed effects were removed if their significance
level was greater than 0.10 in a stepwise backwards procedure
using log-likelihood ratio tests. No adjustments for multiple testing
were performed. A Wilcox-Mann-Whitney test was performed to
assess difference in work-experience years between the two groups.
For all tests the level of significance set at 0.05.
Results
In total, training sessions were provided at 31 PHCCs involving
130 GPs. All GPs have voluntary participated. Two GPs could not
participate in the assessment process as they were attending
patients; the remaining present 128 GPs completed the question-
naire both pre and post training. The average number of GPs who
participated at a PHCC was 4.3 (median: 3; range 1–12). In total
106 GPs attended the symposium, of which 76 completed both the
pre- and post- training questionnaire. Fifty-four of these had not
attended the trainings in the PHCCs, while 22 attended both. The
overall study population is presented in figure 1.
The clinicians attending the PHCC session had more years
work-experience than those attending the symposium (p= 0.007).
The median amount of years of work experience of clinicians
attending the PHCC session was 9 years, with a minimum of one
year and a maximum of thirty-three years. Participants at the
symposium ranged in work experience from 0 to 27 years (median
9 years). Of the 182 participating clinicians 35 (19%) had more
than 20 years experience. Of these, 29 attended the PHCC
sessions, while only 6 attended the symposium session.
Symptoms
The overall gain over both trainings was an increase from an
average of 1.6 to 4.9 symptoms correctly identified (p,0.0001).
However, in comparison with the PHCC group, the symposium
group had a smaller overall improvement (p = 0.01). Prior to the
training sessions an average of 1.4 symptoms were correctly listed
at the PHCCs versus 1.7 at the symposium (p= 0.30). After
training the average number of correct symptoms listed was 5.3 in
the PHCC versus 4.5 at the symposium (Table 1).
There were no difference between GPs with less work
experience (0–10 years) and those with moderate work experience
(11–20 years) (p = 0.46). However compared with these GPs, GPs
with longer work experience (20+years) on average listed more
symptoms correctly prior to training (1.9 vs. 1.5; p = 0.04), but
gained less from the training sessions (4.3 vs. 5.0; p,0.0001). In
the PHCC pre-training questionnaire 71% (129/182) of the GPs
correctly identified neck mass as one of the correct symptoms of
NPC, however only a few GPs could describe symptoms from one
of the other 3 categories in the pre-training assessment (Figure 2).
Post training there was an increase of correct symptoms for the
non-neck mass categories.
Training decreased the number of incorrect symptoms listed by
GPs from 2.0 pre-training to 0.9 post-training (p,0.0001). As with
the correctly identified symptoms, this improvement was higher
for GPs attending the PHCC training than those attending the
symposium (see Table 2; p,0.0001). However GPs attending the
symposium recorded fewer incorrect symptoms pre-training than
those attending the PHCC sessions (see Table 2; p = 0.002). There
was no association between the number of incorrect symptoms and
number of years of work experience (p= 0.85).
Risk Factors
The number of correctly listed risk factors increased after the
training sessions from 1.5 pre-training to 4.1 post-training
(p,0.0001). This improvement was not affected by training
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Table 1. The mean number of accurately listed symptoms
both pre and post training, by GPs attending the PHCC and
the symposium sessions.
Pre-training Post-training
Symptoms
correct 95% CI
Symptoms
correct 95% CI
PHCC 1.5 (1.3–1.7) 5.3 (5.0–5.6)
Symposium 1.7 (1.4–2.0) 4.5 (4.1–5.0)
doi:10.1371/journal.pone.0032756.t001
Table 2. The mean number of incorrect symptoms listed in
the pre- and post-training assessments by GPs attending the
PHCC and symposium training sessions.
Pre-training Post-training
Symptoms
incorrect 95% CI
Symptoms
incorrect 95% CI
PHCC 2.4 (2.1–2.8) 0.5 (0.4–0.6)
Symposium 1.6 (1.2–2.0) 1.2 (0.9–1.6)
doi:10.1371/journal.pone.0032756.t002
Figure 2. Percentage of correct answers about the symptoms given by the GPs. a) Percentage of correct symptoms from the four different
catagories given by GPs with less than 20 years of work experience. b) Percentage of correct symptoms from the four different catagories given by
GPs with more than 20 years of work experience. (1) presence of tumour mass in the nasopharynx; (2) dysfunction of the eustachian tube, associated
with the lateroposterior extension of the tumour to the paranasopharyngeal space; (3) skull-base erosion and palsy of the fifth and sixth cranial
nerves, associated with the superior extension of the tumour; (4) neck masses.
doi:10.1371/journal.pone.0032756.g002
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format: PHCC vs. symposium (p= 0.76), nor was the number of
years worked related to the number of correct risk factors listed by
GPs (p = 0.37). GPs attending the symposium knew more risk
factors prior to training (and therefore after training) than those
attending the PHCC only (p = 0.001) (Table 3).
Likewise, the number of incorrect risk factors decreased after
training (see Table 4; p = 0.004); this improvement was not
different between those GPs attending the PHCC or symposium
sessions (p = 0.16); there was no association between the number of
incorrect risk factors and number of years worked (p = 0.13); and
GPs attending the symposium listed fewer incorrect risk factors
pre-training than those attending the PHCC training (p = 0.02).
Age of NPC presentation and peak incidence of age
group
The questionnaire also contained questions about the youngest
age of presentation and the peak age of incidence. GPs more often
answered incorrectly the youngest age at presentation when
compared with the peak age at presentation question (p = 0.03; see
Table 5). The training sessions resulted in an improvement in
knowledge (p,0.0001), with the PHCC training resulting in a
slightly higher improvement than the symposium training
(p = 0.04). There was no difference between GPs who had worked
0–10 years and those who had worked 11–20 years (p = 0.88),
while GPs with the longest working experience (20+ years) more
often got the youngest age of presentation question wrong
(p = 0.03).
Assessment of loss of recall: GPs attended who attended
both training sessions
GPs who attended both the PHCC and the symposium training
sessions had a small reduction in the number of symptoms
correctly identified between the end of the PHCC session and the
start of the symposium session (5.5 vs. 4.2; p = 0.25), however this
was still a gain when compared to their pre-training knowledge
(4.2 vs. 1.3; p,0.0001). Strikingly, GPs who came back for a
second training session recorded twice the number of incorrect
symptoms prior to the symposium training (1.1 vs. 0.5; p = 0.05),
however this was still a large reduction on the number of errors
made prior to the PHCC training (1.1 vs. 2.8; p,0.0001). GPs
who came back for a second training session recorded slightly
fewer correct risk factors pre-symposium training as compared to
PHCC post-training (4.1 vs. 3.2; p = 0.11), but a significant
increase when compared to their knowledge prior to their first
training session (1.6 vs. 3.2; p = 0.0008). Similarly there was a
decrease in the probability of correctly identifying the youngest
and peak ages at presentation (Youngest: 84% vs. 59%; Peak: 90%
vs. 72%; p= 0.39), however GPs still knew more than what they
knew prior to the PHCC session (Youngest: 13% vs. 59%; Peak:
22% vs. 72%; p,0.0001).
Discussion
NPC has a high incidence and mortality in Indonesia with late
diagnosis being one of the reasons for numerous advanced disease
and high mortality. GPs working in a PHCC are the first line of
care for patients in need of medical attention. For a correct and
early diagnosis of NPC the knowledge of these GPs, especially
concerning early-stage symptoms is crucial. In a prior study in
Yogyakarta, Central-Java, we have shown that the knowledge on
NPC and related symptoms among GP’s working in PHCCs is
insufficient for the recognition of NPC and to initiate appropriate
referral. Our on-going studies in the Yogyakarta province and the
study from the Jakarta region presented here confirm these results;
the GPs working in the Jakarta region have, similar to the
Yogyakarta region, insufficient knowledge to refer NPC suspects to
the hospital. Besides confirmation of the lack of knowledge, we
investigated if improvement of knowledge is possible by introduc-
ing a focussed education program. This is the first study that
examines the effect of different teaching methods to educate
Indonesian GPs on NPC. Early diagnosis will influence the type of
treatment patient require; only in advanced stage of disease
additional chemotherapy is required, while in early stages
radiotherapy alone is sufficient. The addition of chemotherapy
to the treatment leads to more serious side effects and a general
weakening of the patient. Furthermore, early diagnosis of NPC
Table 3. The mean number of correctly identified risk factors
listed in the pre- and post-training by GPs attending the PHCC
and symposium sessions.
Pre-training Post-training
Risk factors
correct 95% CI
Risk factors
correct 95% CI
PHCC 1.3 (1.1–1.5) 3.8 (3.5–4.1)
Symposium 1.6 (1.4–1.9) 4.7 (4.2–5.3)
doi:10.1371/journal.pone.0032756.t003
Table 4. The mean number of incorrect risk factors listed in
the pre- and post-training assessments by GPs attending the
PHCC and the symposium sessions.
Pre-training Post-training
Risk factors
incorrect 95% CI
Risk factors
incorrect 95% CI
PHCC 0.8 (0.6–1.0) 0.6 (0.4–0.7)
Symposium 0.5 (0.4–0.7) 0.4 (0.3–0.5)
doi:10.1371/journal.pone.0032756.t004
Table 5. The probability (%) of correctly answering questions
concerning youngest age of presentation and peak age of
incidence.
Pre-training Post-training
Work
Exp.
%
Correct 95% CI
%
Correct 95% CI
Youngest
Age
PHCC 0–20 yrs 22 (16–30) 71 (63–78)
20+ yrs 13 (8–22) 57 (43–71)
Symposium 0–20 yrs 25 (17–37) 59 (46–70)
20+ yrs 15 (8–29) 43 (27–61)
Peak Age PHCC 0–20 yrs 32 (25–40) 81 (74–86)
20+ yrs 41 (28–55) 86 (77–92)
Symposium 0–20 yrs 20 (13–31) 52 (40–63)
20+ yrs 27 (15–45) 61 (43–76)
doi:10.1371/journal.pone.0032756.t005
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should lead to fewer patients presenting with distant metastasis
who currently cannot be treated with curative intent.
In Malaysia prior studies have proved that the lack of awareness
and knowledge of primary health care workers is one of the main
reasons for delayed diagnosis. Given that presenting stage is the
most important prognostic factor, the appropriate training of GPs
is critical [21]. The relevance of adequate referral by GPs for head
and neck carcinomas has been showen by Alho et al. [22], who
found that in 20% of the 221 patients, subsequently to be
diagnosed with head and neck carcinoma, were initially send
home without referral. The risk of death in this group was
significantly higher when compared with the patients who were
immediately referred or received a follow up appointment.
Although not statistically significant, patients who were initially
sent home had higher cancer stage at diagnosis.
The same research team has also showen that time between GP
referral and final diagnosis is a significant factor in patient
outcome in other head and neck cancers [23] Long delay in
primary care resulted in a significant worsened prognosis
especially by patients with laryngeal carcinoma [24].
Educational sessions at PHCCs by a team of two GPs and a
symposium by local head and neck surgeons have both shown to
be effective. In general, the pre-test knowledge at the symposium
was higher than in the PHCC. The reason for this could be that
visit in the PHCC was unannounced, while for the symposium the
GPs received an invitation so they had some time to prepare for
the meeting, or were being pre-informed about the NPC topic by
colleagues who had previously attended the PHCC training
sessions.
Comparing the two different training formats we see a greater
gain in knowledge at the PHCCs. One explanation for this could
be that the PHCC sessions provided a more focused approach and
direct contact/confrontation with participants. Another reason
could be that the lecture at the symposium was more extensive and
perhaps did not delve too deeply into the most important aspects,
but rather covered all aspects of NPC to broadly.
On the other hand, during the symposium GPs also received
practical education for performing physical examination of the
head and neck region and a testimonial of a NPC patient. We
expect this additional training aspect to be important for the
recognition of NPC patients. Another remarkable result is that the
more experienced GPs knew more prior to the training but
learned less in both interventions. Perhaps in future the education
of longer serving doctors should be adjusted.
For the four different categories of symptoms, as described by
Wei et al, we see at the pre-test the most often and only given
correct answer is neck mass, which only occurs in advanced NPC.
At the post test the GPs are also aware of symptoms in the other
categories (see figure 2), most importantly, including symptoms of
early stage NPC.
The doctors who attended both trainings showed a small decline
in knowledge prior to the symposium when compared with their
results directly after the session in the PHCC. However they still
knew far more than what they knew prior to the PHCC session.
Unfortunately we are only able to assess recall over an average of 8
days. It would be of great interest to assess changes in NPC
awareness over a much longer duration.
Visiting the PHCC was a time consuming exercise as the PHCC
are scattered throughout Jakarta. The symposium was more time-
effective with all the general practitioners present at the same
venue and date. Accreditation points are only accrued after the
symposium and not the PHCC sessions, thus making the
symposium session more attractive for the GPs. However, every
GP visited in the PHCC was willing to participate, perhaps
stimulated or convinced by the approval letter from the head of
public health department of the Jakarta province.
Although this study demonstrates the effectiveness of education
GPs about NPC, the time between the pre- and post-training
assessments is short. The goal of achieving a down-staging of NPC
at presentation is still to be proven. We believe the recent
introduction of an online data management service will aid in the
confirmation of earlier stage presentation of patients with NPC
[25].
The NPC WHO III histological subtype is the most prevalent
type in SE-Asia and Indonesia. This type is causally associated
with the Epstein-Barr virus (EBV). Prior studies have shown that
EBV-related markers can be used for early detection (screening)
and prognostic monitoring. These markers include EBV (IgA)
serology and EBV-DNA load since NPC patients have character-
istic elevated IgG and IgA antibody titres to several EBV encoded
antigens as well as increased EBV-DNA derived from shed
(apoptotic) fragments from the tumour into the circulation.
Increased IgA antibody levels are found against early antigen
(EA), viral capsid antigen (VCA) and the latent Epstein-Barr
nuclear antigen 1 (EBNA1) as well as inhibitory antibodies to the
EBV specific DNase [26,27]. These antibody responses against
defined viral antigens are the basis of a proposed screening test for
NPC in high-risk populations [28–30]. Recent insight in the
molecular basis and diversity of anti EBV IgA and IgG responses
allowed the development of more defined serological tools [31–
35]. A possible assay in the future could be EBV DNA load in the
circulation and in nasopharyngeal brushings since both have been
detected in a higher proportion of NPC patients than controls [36–
40]. Especially EBV IgA serology testing appears to fulfil criteria as
a screening tool in the future, since the price is relative low and
easy to use when combined with finger-prick blood sampling
[34,41]. Future education programs should include referencing to
the availability of improved diagnostic procedures for screening
and early detection. Improved education combined with a
screening method could be a cheap and sensitive screening
method for NPC in Indonesia and other high incidence countries.
Importantly, the decision for serological or EBV-DNA based
analysis has to be based on complaints and duration of complaints
registered and interpreted by the GP. Our on-going research is
focussed on finding the best decision tree to accomplish effective
early stage diagnosis in NPC high-risk groups (Hutajulu et al;
manuscript submitted).
Currently the NPC awareness programme takes place in
Jakarta, Yogyakarta and Surabaya. Hopefully in the future this
program can be expanded to include all of Indonesia. We also
hope to raise public awareness on importance of early-stage cancer
and how and when to consult a GP in all layers of Indonesian
society. However, as a first step we aim to raise the level of relevant
knowledge in primary health care workers. Similar campaigns to
educate society on breast and cervical cancer have proven to be
highly effective [42,43]. Education of the GPs and society, and
combined with improved diagnostic testing will ideally result in
earlier detection of NPC, better treatment outcomes, and
increased overall prognosis.
Conclusion
The current level of knowledge regarding NPC diagnosis is
poor, potentially contributing to an increased rate of late stage
diagnosis. Additional training sessions increased the knowledge of
key symptoms, in particular early-stage symptoms. This increase
was observed after conducting both types of training format: a
centralized symposium and lectures in local PHCC. With
improved knowledge of NPC patients should be referred to
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hospital at an earlier stage of NPC and as such should have an
improved chance of survival.
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